[Amlexanox has an acute bronchodilator effect in patients with aspirin-induced asthma (AIA)] - PubMed (original) (raw)
[Article in Japanese]
Affiliations
- PMID: 8230896
Clinical Trial
[Amlexanox has an acute bronchodilator effect in patients with aspirin-induced asthma (AIA)]
[Article in Japanese]
S Imokawa et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Aug.
Abstract
Recently, we have reported that a nebulized solution of sodium cromoglycate (SCG) (Intal), a well known antiallergic agent, has an acute bronchodilator effect in patients with aspirin-induced asthma (AIA). Amlexanox is an antiallergic agent, with a structure similar to that of SCG. Therefore, we investigated the acute bronchodilator effect of amlexanox administered orally to adult asthmatics, focusing on a comparison between AIA and non-AIA patients. Fifteen patients participated, 8 having AIA and 7 non-AIA. After performing spirometry during remission, they were administered either amlexanox or placebo using a randomized double-blind protocol. Spirometry was then performed at 30, 60, 90 min, 2 h, and 3 h after administration. The placebo used was lactose. In the AIA group, FEV1 was significantly improved after administration of amlexanox. However, FEV1 was significantly decreased after placebo administration. On the other hand, in the non-AIA group, FEV1 was not changed after administration of either of the drugs. From these results, we conclude that amlexanox has an acute bronchodilator effect only in AIA patients.
Similar articles
- [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)].
Imokawa S, Sato A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, Chida K. Imokawa S, et al. Arerugi. 1992 Oct;41(10):1515-20. Arerugi. 1992. PMID: 1482300 Clinical Trial. Japanese. - Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma.
Szczeklik A, Mastalerz L, Nizankowska E, Cmiel A. Szczeklik A, et al. Am J Respir Crit Care Med. 1996 Feb;153(2):567-71. doi: 10.1164/ajrccm.153.2.8564099. Am J Respir Crit Care Med. 1996. PMID: 8564099 Clinical Trial. - Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma.
Rolla G, Di Emanuele A, Dutto L, Marsico P, Nebiolo F, Corradi F, Brussino L, Bucca C. Rolla G, et al. Allergy. 2004 Aug;59(8):827-32. doi: 10.1111/j.1398-9995.2004.00502.x. Allergy. 2004. PMID: 15230814 - Pathophysiological basis of asthma management.
Herzog H. Herzog H. Allergol Immunopathol (Madr). 1981;Suppl 9:143-54. Allergol Immunopathol (Madr). 1981. PMID: 6762077 Review. No abstract available. - [New approaches in the pathogenesis of asthma affecting treatment patterns].
Laitinen LA, Haahtela T. Laitinen LA, et al. Duodecim. 1988;104(6):439-45. Duodecim. 1988. PMID: 3053138 Review. Finnish. No abstract available.
Cited by
- TBK1 and GABARAP family members suppress Coxsackievirus B infection by limiting viral production and promoting autophagic degradation of viral extracellular vesicles.
Sawaged S, Mota T, Piplani H, Thakur R, Lall D, McCabe E, Seo S, Sutterwala FS, Feuer R, Gottlieb RA, Sin J. Sawaged S, et al. PLoS Pathog. 2022 Aug 31;18(8):e1010350. doi: 10.1371/journal.ppat.1010350. eCollection 2022 Aug. PLoS Pathog. 2022. PMID: 36044516 Free PMC article. - Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
Quan MY, Song XJ, Liu HJ, Deng XH, Hou HQ, Chen LP, Ma TZ, Han X, He XX, Jia Z, Guo L. Quan MY, et al. J Neuroinflammation. 2019 Mar 1;16(1):52. doi: 10.1186/s12974-019-1438-z. J Neuroinflammation. 2019. PMID: 30823934 Free PMC article. - Amlexanox: A Novel Therapeutic for Atopic, Metabolic, and Inflammatory Disease.
Dosanjh A, Won CY. Dosanjh A, et al. Yale J Biol Med. 2020 Dec 29;93(5):759-763. eCollection 2020 Dec. Yale J Biol Med. 2020. PMID: 33380937 Free PMC article. Review. - Critical Role of Cytosolic DNA and Its Sensing Adaptor STING in Aortic Degeneration, Dissection, and Rupture.
Luo W, Wang Y, Zhang L, Ren P, Zhang C, Li Y, Azares AR, Zhang M, Guo J, Ghaghada KB, Starosolski ZA, Rajapakshe K, Coarfa C, Li Y, Chen R, Fujiwara K, Abe JI, Coselli JS, Milewicz DM, LeMaire SA, Shen YH. Luo W, et al. Circulation. 2020 Jan 7;141(1):42-66. doi: 10.1161/CIRCULATIONAHA.119.041460. Epub 2019 Dec 30. Circulation. 2020. PMID: 31887080 Free PMC article. - The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis.
Zhao P, Sun X, Liao Z, Yu H, Li D, Shen Z, Glass CK, Witztum JL, Saltiel AR. Zhao P, et al. JCI Insight. 2022 Sep 8;7(17):e155552. doi: 10.1172/jci.insight.155552. JCI Insight. 2022. PMID: 35917178 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical